MedTrace Logo

HemoSonics - UTMB Cardiac Surgery Study

NCT03988465 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-07-01

No results posted yet for this study

Summary

This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the Quantra QPlus Cartridge in patients undergoing cardiac surgery utilizing cardiopulmonary bypass, including the placement of a ventricular access device.

Conditions

  • Blood Loss, Surgical

Interventions

DIAGNOSTIC_TEST

Quantra System

Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Sponsors & Collaborators

  • HemoSonics LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-19
Primary Completion
2020-03-13
Completion
2020-05-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03988465 on ClinicalTrials.gov